New Risk • May 31
New major risk - Revenue and earnings growth Earnings have declined by 12% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Negative equity (-CA$1.7m). Earnings have declined by 12% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (14% average weekly change). Market cap is less than US$100m (CA$24.4m market cap, or US$17.7m). Announcement • May 19
Dr. Phone Fix Canada Corporation announced that it expects to receive $2.5 million in funding Dr. Phone Fix Canada Corporation announced a non-brokered private placement of convertible debenture units of the company for gross proceeds of $2,500,000 on May 19, 2026. Each convertible debenture unit is comprised of (i) one $1,000 principal amount unsecured convertible debenture of the Company and ( i) 3,125 common share purchase warrants of the Company, representing 50% warrant coverage based on the number of common shares issuable upon conversion of the Convertible Debenture. The Convertible Debentures shall bear interest at a rate of 10% per annum from the closing date of the offering, payable annually. The outstanding principal amount of each Convertible Debenture shall be convertible at the option of the holder thereof, at any time on and after the Closing Date and prior to the date that is 24 months from the date of issuance of such Convertible Debenture into common shares of the Company at a conversion price per Common Share equal to $0.16. Each Warrant shall be exercisable by the holder to acquire one Common Share at an exercise price of $0.22 any time on or after the closing date until the date that is 24 months from the date of issuance of such Warrant. Beginning on the date that is four (4) months and one (1) day following the Closing Date, if the closing price of the Common Shares on the TSX Venture Exchange has been at or above $0.40 for ten (10) consecutive trading days, the Company has the right but not an obligation to accelerate the expiration date of the Warrants to a date that is 30 days following a press release announcing acceleration. At the maturity date, all principal amount outstanding together with any unpaid interest on the Convertible Debentures will be repayable by the Company in cash. All securities issued pursuant to the offering, including any Common Shares issuable upon conversion of the Convertible Debentures or exercise of the Warrants, are subject to a statutory hold period of four months and one day from the closing date, in accordance with applicable securities laws and TSXV policies. The Company may also concurrently offer and sell Units outside of Canada on a non-brokered, unregistered private placement basis to a limited number of "accredited investors" (as defined in Regulation D under the United States Securities Act of 1933). The offering may close in tranches with the final tranche of the offering anticipated to close on or around May 29, 2026, and remains subject to the receipt of al necessary regulatory approvals, including the approval of the TSXV. Finder's fees may be payable by the Company on a portion of the offering in accordance with applicable securities laws. Reported Earnings • May 05
Full year 2025 earnings released: CA$0.03 loss per share (vs CA$0.57 loss in FY 2024) Full year 2025 results: CA$0.03 loss per share. Revenue: CA$12.2m (up 19% from FY 2024). Net loss: CA$5.21m (loss widened 43% from FY 2024). 